Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06VMJ
|
||||
| Former ID |
DCL001113
|
||||
| Drug Name |
Melogliptin
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 2 | [548067] | ||
| Company |
Glenmark pharma
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [537022] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

